Pages that link to "Q33917658"
The following pages link to Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? (Q33917658):
Displaying 50 items.
- ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway (Q33560337) (← links)
- Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma (Q33658666) (← links)
- Revisiting the hallmarks of cancer (Q33732986) (← links)
- Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1. (Q33736706) (← links)
- Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment (Q37694431) (← links)
- Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures. (Q37704991) (← links)
- In vivo Reprogramming of Cancer Metabolism by MYC. (Q37746816) (← links)
- Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo. (Q38688183) (← links)
- Glutamine fuels proliferation but not migration of endothelial cells (Q38703910) (← links)
- Differential expression of genes related to glucose metabolism in domesticated pigs and wild boar (Q38783947) (← links)
- Metabolic heterogeneity signature of primary treatment-naïve prostate cancer (Q38810786) (← links)
- Mitochondrial dynamics as regulators of cancer biology (Q39084933) (← links)
- The role of RNA alternative splicing in regulating cancer metabolism. (Q39253959) (← links)
- The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. (Q39329214) (← links)
- New Challenges to Study Heterogeneity in Cancer Redox Metabolism (Q39458558) (← links)
- Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells. (Q41098487) (← links)
- Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics (Q41173095) (← links)
- Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma. (Q41328292) (← links)
- The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy. (Q41339597) (← links)
- Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death (Q41718480) (← links)
- Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis (Q41996952) (← links)
- ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells (Q42211295) (← links)
- Microenvironmental cooperation promotes early spread and bistability of a Warburg-like phenotype (Q42212032) (← links)
- Pyruvate attenuates the anti-neoplastic effect of carnosine independently from oxidative phosphorylation (Q42316514) (← links)
- Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia (Q45205976) (← links)
- A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. (Q45945650) (← links)
- Cytotoxicity, Oxidative Stress, Cell Cycle Arrest, and Mitochondrial Apoptosis after Combined Treatment of Hepatocarcinoma Cells with Maleic Anhydride Derivatives and Quercetin. (Q46256497) (← links)
- Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation (Q46283642) (← links)
- A novel mammalian glucokinase exhibiting exclusive inorganic polyphosphate dependence in the cell nucleus (Q46505469) (← links)
- Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines. (Q47104746) (← links)
- Metabolic Signaling to Epigenetic Alterations in Cancer (Q47107592) (← links)
- CDK8 Kinase Activity Promotes Glycolysis. (Q47129821) (← links)
- PKM2 in carcinogenesis and oncotherapy (Q47153446) (← links)
- A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis (Q47162494) (← links)
- A New Perspective on the Heterogeneity of Cancer Glycolysis. (Q47208178) (← links)
- Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis (Q47301565) (← links)
- HMGB1 Controls Liver Cancer Initiation through YAP-dependent Aerobic Glycolysis. (Q47391467) (← links)
- Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis (Q47421551) (← links)
- Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review (Q47599535) (← links)
- Targeting Metabolism for Cancer Therapy. (Q47646742) (← links)
- Two-color vibrational imaging of glucose metabolism using stimulated Raman scattering. (Q47927103) (← links)
- Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. (Q48130799) (← links)
- Lysophosphatidic Acid Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response (Q48131479) (← links)
- Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies (Q48274382) (← links)
- Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs (Q49188115) (← links)
- Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment (Q49505837) (← links)
- The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer (Q49887915) (← links)
- Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis (Q49920405) (← links)
- On reprogramming of tumor cells metabolism: detection of glycogen in the cell lines of hepatocellular origin with various degrees of dedifferentiation. (Q49993588) (← links)
- Validity and clinical impact of glucose transporter 1 expression in colorectal cancer (Q50074585) (← links)